chr6-69697573-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018368.4(LMBRD1):​c.1407T>A​(p.Asp469Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.39 in 1,596,448 control chromosomes in the GnomAD database, including 125,478 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9688 hom., cov: 32)
Exomes 𝑓: 0.40 ( 115790 hom. )

Consequence

LMBRD1
NM_018368.4 missense

Scores

3
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.44

Publications

34 publications found
Variant links:
Genes affected
LMBRD1 (HGNC:23038): (LMBR1 domain containing 1) This gene encodes a lysosomal membrane protein that may be involved in the transport and metabolism of cobalamin. This protein also interacts with the large form of the hepatitis delta antigen and may be required for the nucleocytoplasmic shuttling of the hepatitis delta virus. Mutations in this gene are associated with the vitamin B12 metabolism disorder termed, homocystinuria-megaloblastic anemia complementation type F.[provided by RefSeq, Oct 2009]
LMBRD1 Gene-Disease associations (from GenCC):
  • methylmalonic aciduria and homocystinuria type cblF
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.4306774E-4).
BP6
Variant 6-69697573-A-T is Benign according to our data. Variant chr6-69697573-A-T is described in ClinVar as Benign. ClinVar VariationId is 138124.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.527 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018368.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LMBRD1
NM_018368.4
MANE Select
c.1407T>Ap.Asp469Glu
missense
Exon 14 of 16NP_060838.3
LMBRD1
NM_001363722.2
c.1188T>Ap.Asp396Glu
missense
Exon 14 of 16NP_001350651.1
LMBRD1
NM_001367271.1
c.1188T>Ap.Asp396Glu
missense
Exon 14 of 16NP_001354200.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LMBRD1
ENST00000649934.3
MANE Select
c.1407T>Ap.Asp469Glu
missense
Exon 14 of 16ENSP00000497690.1
LMBRD1
ENST00000370570.6
TSL:1
c.1188T>Ap.Asp396Glu
missense
Exon 14 of 16ENSP00000359602.1
LMBRD1
ENST00000649011.1
c.1473T>Ap.Asp491Glu
missense
Exon 15 of 17ENSP00000497575.1

Frequencies

GnomAD3 genomes
AF:
0.337
AC:
51203
AN:
151820
Hom.:
9683
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.160
Gnomad AMI
AF:
0.398
Gnomad AMR
AF:
0.378
Gnomad ASJ
AF:
0.431
Gnomad EAS
AF:
0.543
Gnomad SAS
AF:
0.443
Gnomad FIN
AF:
0.339
Gnomad MID
AF:
0.456
Gnomad NFE
AF:
0.405
Gnomad OTH
AF:
0.368
GnomAD2 exomes
AF:
0.394
AC:
98775
AN:
250410
AF XY:
0.402
show subpopulations
Gnomad AFR exome
AF:
0.152
Gnomad AMR exome
AF:
0.379
Gnomad ASJ exome
AF:
0.428
Gnomad EAS exome
AF:
0.551
Gnomad FIN exome
AF:
0.339
Gnomad NFE exome
AF:
0.402
Gnomad OTH exome
AF:
0.399
GnomAD4 exome
AF:
0.396
AC:
571560
AN:
1444510
Hom.:
115790
Cov.:
28
AF XY:
0.399
AC XY:
287062
AN XY:
719688
show subpopulations
African (AFR)
AF:
0.153
AC:
5073
AN:
33224
American (AMR)
AF:
0.380
AC:
16958
AN:
44630
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
11248
AN:
25982
East Asian (EAS)
AF:
0.545
AC:
21533
AN:
39490
South Asian (SAS)
AF:
0.443
AC:
37992
AN:
85796
European-Finnish (FIN)
AF:
0.348
AC:
18320
AN:
52626
Middle Eastern (MID)
AF:
0.445
AC:
2551
AN:
5734
European-Non Finnish (NFE)
AF:
0.396
AC:
434235
AN:
1097218
Other (OTH)
AF:
0.395
AC:
23650
AN:
59810
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
14980
29961
44941
59922
74902
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13336
26672
40008
53344
66680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.337
AC:
51225
AN:
151938
Hom.:
9688
Cov.:
32
AF XY:
0.337
AC XY:
25050
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.160
AC:
6638
AN:
41490
American (AMR)
AF:
0.379
AC:
5779
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.431
AC:
1497
AN:
3470
East Asian (EAS)
AF:
0.544
AC:
2808
AN:
5166
South Asian (SAS)
AF:
0.444
AC:
2142
AN:
4826
European-Finnish (FIN)
AF:
0.339
AC:
3575
AN:
10560
Middle Eastern (MID)
AF:
0.456
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
0.405
AC:
27506
AN:
67852
Other (OTH)
AF:
0.371
AC:
783
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1660
3320
4979
6639
8299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.397
Hom.:
9239
Bravo
AF:
0.330
TwinsUK
AF:
0.392
AC:
1455
ALSPAC
AF:
0.396
AC:
1526
ESP6500AA
AF:
0.155
AC:
681
ESP6500EA
AF:
0.400
AC:
3437
ExAC
AF:
0.392
AC:
47546
Asia WGS
AF:
0.471
AC:
1637
AN:
3476
EpiCase
AF:
0.409
EpiControl
AF:
0.412

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Methylmalonic aciduria and homocystinuria type cblF Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 29, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0079
T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.48
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Benign
0.68
T
MetaRNN
Benign
0.00024
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.97
L
PhyloP100
3.4
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
0.050
N
REVEL
Benign
0.12
Sift
Benign
0.33
T
Sift4G
Benign
0.37
T
Polyphen
0.013
B
Vest4
0.068
MutPred
0.081
Gain of glycosylation at P471 (P = 0.1041)
MPC
0.093
ClinPred
0.0091
T
GERP RS
2.0
Varity_R
0.037
gMVP
0.42
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12648; hg19: chr6-70407465; COSMIC: COSV65296211; API